These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34525166)

  • 41. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin.
    Kim S; Diab R; Joubert O; Canilho N; Pasc A
    Colloids Surf B Biointerfaces; 2016 Apr; 140():161-168. PubMed ID: 26752213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties.
    Encinas N; Angulo M; Astorga C; Colilla M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2019 Jan; 84():317-327. PubMed ID: 30529082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine.
    Zhang H; Shahbazi MA; Mäkilä EM; da Silva TH; Reis RL; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2013 Dec; 34(36):9210-9. PubMed ID: 24008036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoporous hybrid core-shell nanoparticles for sequential release.
    Jahns M; Warwas DP; Krey MR; Nolte K; König S; Fröba M; Behrens P
    J Mater Chem B; 2020 Jan; 8(4):776-786. PubMed ID: 31898715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sol-gel silica controlled release thin films for the inhibition of methicillin-resistant Staphylococcus aureus.
    Bhattacharyya S; Agrawal A; Knabe C; Ducheyne P
    Biomaterials; 2014 Jan; 35(1):509-17. PubMed ID: 24099711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.
    Pei Y; Mohamed MF; Seleem MN; Yeo Y
    J Control Release; 2017 Dec; 267():133-143. PubMed ID: 28797580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release.
    Chen X; Xu C; He H
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1085-1089. PubMed ID: 31279530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic Core-Shell Silica Nanoparticles with Large Radial Mesopores for siRNA Delivery.
    Xiong L; Bi J; Tang Y; Qiao SZ
    Small; 2016 Sep; 12(34):4735-42. PubMed ID: 27199216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
    Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
    Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus.
    Paiva MRB; Andrade GF; Dourado LFN; Castro BFM; Fialho SL; Sousa EMB; Silva-Cunha A
    J Biomater Appl; 2021 Mar; 35(8):1019-1033. PubMed ID: 33290123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
    Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
    J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesoporous silica nanoparticles functionalised with a photoactive ruthenium(ii) complex: exploring the formulation of a metal-based photodynamic therapy photosensitiser.
    Ellahioui Y; Patra M; Mari C; Kaabi R; Karges J; Gasser G; Gómez-Ruiz S
    Dalton Trans; 2019 May; 48(18):5940-5951. PubMed ID: 30209497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
    Shah P; Rajput SJ
    Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral delivery of vancomycin by tetraether lipid liposomes.
    Uhl P; Pantze S; Storck P; Parmentier J; Witzigmann D; Hofhaus G; Huwyler J; Mier W; Fricker G
    Eur J Pharm Sci; 2017 Oct; 108():111-118. PubMed ID: 28716758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
    Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
    Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
    Qi G; Li L; Yu F; Wang H
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.